The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Abstract
Sexually transmitted diseases (STDs) constitute an epidemic of tremendous magnitude, with an estimated 18.9 million persons acquiring a new STD each year [1]. Reported disease rates underestimate the true burden of infection because the majority of STDs are asymptomatic and because of underreporting. STDs have far-reaching public health consequences for the sexual and reproductive health of individual persons, as well as for the long-term health and health care costs of the community. The accurate identification and the effective clinical management of STDs represent an important combined strategy necessary to improve reproductive and sexual health and to improve HIV prevention efforts. This is especially relevant to women, adolescents, and infants, because untreated infections frequently result in severe, long-term complications, including facilitation of HIV infection, tubal infertility, adverse pregnancy outcomes, and cancer. For >20 years, the publication of national guidelines by the Centers for Disease Control and Prevention (CDC) for the management of STDs has assisted clinicians with effective guidance on the delivery of optimal STD care. The CDC STD treatment guidelines are the most widely referenced and authoritative source of information on STD treatment and prevention strategies for clinicians who evaluate persons with STDs or those at risk for STDs. The 2006 CDC guidelines for the treatment of sexually transmitted diseases were developed in consultation with public- and private-sector professionals knowledgeable in the management of STDs [2]. An evidence-based systematic review was performed, focusing on peer-reviewed journal articles and abstracts that had become available since publication of the 2002 CDC STD treatment guidelines. Evidence tables were developed from systematic reviews that summarized the study type, population and setting, treatment regimens or other interventions, outcome measures, and potential limitations of the reported findings. This supplement to Clinical Infectious Diseases contains 9 background articles that describe the available evidence in several topic areas included in the 2006 CDC STD treatment guidelines. Current advances and controversies are described in the diagnosis, management, and treatment of various sexually transmitted pathogens and syndromes that have important implications for clinical practice. Chlamydia trachomatis infection is the most common bacterial STD in the United States, with an estimated 3 million cases occurring annually [3]. Reported rates of chlamydial infection have increased dramatically over the past decade, reflecting expansion of chlamydial screening activities, highly sensitive nucleic acid amplification tests, and improvements in information systems used for reporting. However, many women who are at risk for this infection are still not being screened appropriately, reflecting, in part, a lack of awareness among some providers, as well as limited resources. Health care providers frequently rely on screening tests, because asymptomatic infection is common among both men and women. Annual screening of all sexually active women ⩽25 years of age is recommended [4], as is screening of older women with risk factors (e.g., those who have a new sex partner or multiple sex partners). There is insufficient evidence to recommend routine screening for C. trachomatis in sexually active young men on the basis of feasibility, efficacy, and cost-effectiveness; however, screening should be considered in high-prevalence areas, such as adolescent clinics, correctional facilities, and STD clinics. Efficacious therapeutic regimens for chlamydia include azithromycin or doxycycline. Because of the high probability of repeat infection, women should be retested for chlamydial infection 3–4 months after treatment [5]. Clinical experience and limited studies are available to support the efficacy and safety of azithromycin as a recommended regimen in pregnant women. Infections with Neisseria gonorrhoeae account for the second most commonly notifiable disease in the United States [3] and are an important cause of cervicitis, urethritis, proctitis, and pelvic inflammatory disease. Selection of appropriate therapy for gonorrhea is guided by a CDC-sponsored surveillance system (Gonococcal Isolate Surveillance Project) that has monitored gonococcal antimicrobial susceptibility for the past 20 years. Of recent concern, the prevalence of quinolone-resistant N. gonorrhoeae has increased in many areas of the United States and among men who have sex with men, resulting in changes in recommended treatment regimens. The CDC Web site [6] or state and local health departments can provide the most current information on quinolone-resistant N. gonorrhoeae prevalence. Because prevalence can vary greatly by location, state and local public health officials should maintain the capacity to detect and monitor the prevalence of resistant strains. Oral alternatives to quinolones
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fleming, D. T., & Wasserheit, J. N. (1999) · Sexually Transmitted Infections · doi:10.1136/sti.75.1.3 · Cited by 2,271
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
Kreimer, A. R., Clifford, G. M., Boyle, P., & Franceschi, S. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0551 · Cited by 2,184
Sexually transmitted diseases treatment guidelines
Burstein, G. R., & Workowski, K. A. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200308000-00006 · Cited by 2,072
Self-citationMarkowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007) · PsycEXTRA Dataset · doi:10.1037/e601292007-001 · Cited by 1,882
Sexually transmitted disease surveillance.
Schofield, C. B. (1982) · BMJ · doi:10.1136/bmj.284.6318.825-c · Cited by 1,869
Le, M. (2007) · Medical Entomology and Zoology · Cited by 1,624
Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000
Weinstock, H., Berman, S., & Cates, W. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3600604 · Cited by 1,258
Self-citationSexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000
Weinstock, H., Berman, S., & Cates, W. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1111/j.1931-2393.2004.tb00002.x · Cited by 1,153
Self-citationMast, E. E., Weinbaum, C. M., Fiore, A. E., Alter, M. J., Bell, B. P., Finelli, L., Rodewald, L. E., Douglas, J. M., Janssen, R. S., & Ward, J. W. (2006) · PubMed · Cited by 1,132
1993 Sexually Transmitted Diseases Treatment Guidelines
(1994) · Journal of School Health · doi:10.1111/j.1746-1561.1994.tb03287.x · Cited by 918
Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia
Ho, G. Y. F., Burk, R. D., Klein, S., Kadish, A. S., Chang, C. J., Palan, P., Basu, J., Tachezy, R., Lewis, R., & Romney, S. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.18.1365 · Cited by 803
The Hidden Epidemic: Confronting Sexually Transmitted Diseases
(1997) · National Academies Press eBooks · doi:10.17226/5284 · Cited by 726
Lukehart, S. A., Hook, E. W., Baker-Zander, S. A., Collier, A. C., Critchlow, C. W., & Handsfield, H. H. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-11-855 · Cited by 603
Rolfs, R. T., Joesoef, M. R., Hendershot, E. F., Rompalo, A. M., Augenbraun, M. H., Chiu, M., Bolan, G., Johnson, S. C., French, P., Steen, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370504 · Cited by 550
Minkoff, H., Grunebaum, A. N., Schwarz, R. H., Feldman, J., Cummings, M., Crombleholme, W., Clark, L., Pringle, G., & McCormack, W. M. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(84)90392-2 · Cited by 511
Marra, C. M., Maxwell, C. L., Smith, S. L., Lukehart, S. A., Rompalo, A. M., Eaton, M., Stoner, B. P., Augenbraun, M., Barker, D. E., Corbett, J. J., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/381227 · Cited by 491
Chosidow, O. (2000) · The Lancet · doi:10.1016/s0140-6736(99)09458-1 · Cited by 483
Ness, R. B., Soper, D. E., Holley, R. L., Peipert, J., Randall, H., Sweet, R. L., Sondheimer, S. J., Hendrix, S. L., Amortegui, A., Trucco, G., et al. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.121625 · Cited by 414
Danta, M., Brown, D., Bhagani, S., Pybus, O. G., Sabin, C. A., Nelson, M., Fisher, M., Johnson, A. M., & Dusheiko, G. M. (2007) · AIDS · doi:10.1097/qad.0b013e3281053a0c · Cited by 410
Macrolide Resistance in Treponema pallidum in the United States and Ireland
Lukehart, S. A., Godornes, C., Molini, B. J., Sonnett, P., Hopkins, S., Mulcahy, F., Engelman, J., Mitchell, S. J., Rompalo, A. M., Marra, C. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040216 · Cited by 378
Nieuwenhuis, R. F., Ossewaarde, J. M., Götz, H. M., Dees, J., Thio, H. B., Thomeer, M. G. J., den Hollander, J. C., Neumann, M. H. A., & van der Meijden, W. I. (2004) · Clinical Infectious Diseases · doi:10.1086/423966 · Cited by 346
Sexual Risk Factors and Bacterial Vaginosis: A Systematic Review and Meta‐Analysis
Fethers, K. A., Fairley, C. K., Hocking, J. S., Gurrin, L. C., & Bradshaw, C. S. (2008) · Clinical Infectious Diseases · doi:10.1086/592974 · Cited by 337
Parish, L. C., & Witkowski, J. A. (1989) · Sexually Transmitted Diseases · doi:10.1007/978-1-4612-3528-6_12 · Cited by 321
Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis.
Riedner, G., Rusizoka, M., Todd, J., Maboko, L., Hoelscher, M., Mmbando, D., Samky, E., Lyamuya, E., Mabey, D., Grosskurth, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044284 · Cited by 296
SCHACHTER, J., MONCADA, J., LISKA, S., SHAYEVICH, C., & KLAUSNER, J. D. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31817bdd7e · Cited by 293
Bradshaw, C. S., Tabrizi, S. N., Read, T. R. H., Garland, S. M., Hopkins, C. A., Moss, L. M., & Fairley, C. K. (2006) · The Journal of Infectious Diseases · doi:10.1086/499434 · Cited by 263
Prevalence of Trichomonas vaginalis Isolates with Resistance to Metronidazole and Tinidazole
Schwebke, J. R., & Barrientes, F. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00814-06 · Cited by 225
Neurosyphilis in a clinical cohort of HIV-1-infected patients.
Ghanem, K. G., Moore, R. D., Rompalo, A. M., Erbelding, E. J., Zenilman, J. M., & Gebo, K. A. (2008) · AIDS · doi:10.1097/qad.0b013e32830184df · Cited by 212
Van der Bij, A. K., Spaargaren, J., Morre, S. A., Fennema, H. S. A., Mindel, A., Coutinho, R. A., & de Vries, H. J. C. (2006) · Clinical Infectious Diseases · doi:10.1086/498904 · Cited by 188
WHITTINGTON, W. L. H., KENT, C., KISSINGER, P., OH, M. K., FORTENBERRY, J. D., HILLIS, S. E., LITCHFIELD, B., BOLAN, G. A., ST. LOUIS, M. E., FARLEY, T. A., et al. (2001) · Sex Transm Dis · doi:10.1097/00007435-200102000-00011 · Cited by 182
Peterman, T. A., Tian, L. H., Metcalf, C. A., Satterwhite, C. L., Malotte, C. K., DeAugustine, N., Paul, S. M., Cross, H., Rietmeijer, C. A., Douglas, J. M., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-8-200610170-00005 · Cited by 181
Antimicrobial resistance associated with the treatment of bacterial vaginosis
Beigi, R. H., Austin, M. N., Meyn, L. A., Krohn, M. A., & Hillier, S. L. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.05.033 · Cited by 180
Tinidazole Therapy for Metronidazole‐Resistant Vaginal Trichomoniasis
Sobel, J. D., Nyirjesy, P., & Brown, W. (2001) · Clinical Infectious Diseases · doi:10.1086/323034 · Cited by 167
Sexually transmitted diseases and adverse outcomes of pregnancy
Goldenberg, R. L., Andrews, W. W., Yuan, A. C., MacKay, H. T., & Louis, M. E. S. (1997) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30182-9 · Cited by 166
Geisler, W. M., Wang, C., Morrison, S. G., Black, C. M., Bandea, C. I., & Hook, E. W. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318151497d · Cited by 166
Marra, C. M., Maxwell, C. L., Tantalo, L. C., Sahi, S. K., & Lukehart, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/591534 · Cited by 159
Persistence of Mycoplasma genitalium Following Azithromycin Therapy
Bradshaw, C. S., Chen, M. Y., & Fairley, C. K. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003618 · Cited by 154
Fung, M., Scott, K. C., Kent, C. K., & Klausner, J. D. (2006) · Sexually Transmitted Infections · doi:10.1136/sti.2006.024059 · Cited by 147
Jernberg, E. J. N., Moghaddam, A., & Moi, H. (2008) · International Journal of STD & AIDS · doi:10.1258/ijsa.2008.008038 · Cited by 140
Sutton, M. Y., Sternberg, M., Zaidi, A. A., Louis, M. E. S., & Markowitz, L. E. (2005) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000175375.60973.cb · Cited by 140
HOOK, E. W., MARTIN, D. H., STEPHENS, J., SMITH, B. S., & SMITH, K. (2002) · Sexually Transmitted Diseases · doi:10.1097/00007435-200208000-00010 · Cited by 135
Crowell, A. L., Sanders-Lewis, K., & Secor, W. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1407-1409.2003 · Cited by 129
Screening for chlamydial infection: recommendations and rationale.
(2001) · PubMed · Cited by 128
Interventions for treating trichomoniasis in women
Forna, F., & Gülmezoglu, A. M. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000218 · Cited by 128
Decreasing Incidences of Gonorrhea- and Chlamydia-Associated Acute Pelvic Inflammatory Disease
Kamwendo, F., Forslin, L., Bodin, L., et al. (1996) · Sexually Transmitted Diseases · doi:10.1097/00007435-199609000-00007 · Cited by 127
Sexually transmitted diseases in men who have sex with men: An epidemiologic review
Ciesielski, C. A. (2003) · Current Infectious Disease Reports · doi:10.1007/s11908-003-0051-5 · Cited by 118
Ghanem, K. G., Moore, R. D., Rompalo, A. M., Erbelding, E. J., Zenilman, J. M., & Gebo, K. A. (2008) · Clinical Infectious Diseases · doi:10.1086/589295 · Cited by 105
Early Repeated Infections with Trichomonas vaginalis among HIV‐Positive and HIV‐Negative Women
KISSINGER, P. J., Secor, W. E., Leichliter, J. S., Clark, R. A., Schmidt, N., Curtin, E., & Martin, D. H. (2008) · Clinical Infectious Diseases · doi:10.1086/529149 · Cited by 85
Predictors of low physical fitness in a cohort of active-duty U.S. Air Force members
Robbins, A. S., Chao, S. Y., Fonseca, V. P., Snedecor, M. R., & Knapik, J. J. (2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(00)00280-4 · Cited by 82
Predicting chlamydial and gonococcal cervical infection: implications for management of cervicitis
Marrazzo, J. M., Handsfield, H. H., & Whittington, W. L. H. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02140-3 · Cited by 73
Neurologic manifestations of podophyllin toxicity
Filley, C. M., Graff, C., Lacy, J. R., et al. (1982) · Neurology · doi:10.1212/wnl.32.3.308 · Cited by 67
SETHI, G. K., Allason-Jones, E., Richens, J., Annan, N. T., HAWKINS, D. A., Ekbote, A., Alexander, S., & White, J. M. L. (2008) · Sexually Transmitted Infections · doi:10.1136/sti.2008.034348 · Cited by 56
Podophyllum: Suspected Teratogenicity from Topical Application
Karol, M. D., Conner, C. S., Watanabe, A. S., et al. (1980) · Clinical Toxicology · doi:10.3109/15563658008989950 · Cited by 56
Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod
Mashiah, J., & Brenner, S. (2007) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2007.02520.x · Cited by 53
Cited by
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., Halperin, J. J., Steere, A. C., Klempner, M. S., Krause, P. J., Bakken, J. S., Strle, F., Stanek, G., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/508667 · Cited by 2,087
Newman, L., Rowley, J., Vander Hoorn, S., Wijesooriya, N. S., Unemo, M., Low, N., Stevens, G., Gottlieb, S., Kiarie, J., & Temmerman, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143304 · Cited by 1,603
Patel, P., Hanson, D. L., Sullivan, P. S., Novak, R. M., Moorman, A. C., Tong, T. C., Holmberg, S. D., Brooks, J. T., & for the Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00005 · Cited by 942
Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01463-09 · Cited by 914
Metadata
- Authors
- Workowski, K. A., & Berman, S. M.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-01
- Volume
- 44
- Issue
- Supplement 3
- Pages
- S73-S76
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2162847806
- Cited by
- 1,973
- References
- 54
- FWCI
- 101.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.